Skip to main navigation Skip to search Skip to main content

A phase lll randomized open label multicenter study to determine the efficacy and safety of durvalumab in combination with tremelimumab and enfortumab vedotin or durvalumab in combination with enfortumab vedotin for

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date10/27/21 → 10/26/26

Funding

  • AstraZeneca Pharmaceuticals LP: $258,751.25